Future directions include studying larger cohorts of tauopathies, including ‘pure’ AD, ‘pure’ PSP, and PSP with AD co-pathology, to more precisely delineate the extent to which RT-QuIC can measure isoform-specific tau burden in a neuroanatomic manner.﻿ Here, MAPT is linked to Alzheimer disease.